These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16470130)

  • 1. Variability in the P6gag domains of HIV-1 involved in viral budding.
    Holguín A; Alvarez A; Soriano V
    AIDS; 2006 Feb; 20(4):624-7. PubMed ID: 16470130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-TSG101 interface: recent advances in a budding field.
    Freed EO
    Trends Microbiol; 2003 Feb; 11(2):56-9. PubMed ID: 12598123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
    Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO
    J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
    Martin-Serrano J; Zang T; Bieniasz PD
    Nat Med; 2001 Dec; 7(12):1313-9. PubMed ID: 11726971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.
    Strack B; Calistri A; Craig S; Popova E; Göttlinger HG
    Cell; 2003 Sep; 114(6):689-99. PubMed ID: 14505569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
    Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
    PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1.
    Fujii K; Hurley JH; Freed EO
    Nat Rev Microbiol; 2007 Dec; 5(12):912-6. PubMed ID: 17982468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Demirov DG; Ono A; Orenstein JM; Freed EO
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
    Bouamr F; Houck-Loomis BR; De Los Santos M; Casaday RJ; Johnson MC; Goff SP
    J Virol; 2007 Mar; 81(6):2909-22. PubMed ID: 17182674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding.
    Camus G; Segura-Morales C; Molle D; Lopez-Vergès S; Begon-Pescia C; Cazevieille C; Schu P; Bertrand E; Berlioz-Torrent C; Basyuk E
    Mol Biol Cell; 2007 Aug; 18(8):3193-203. PubMed ID: 17538020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C.
    Sharma S; Arunachalam PS; Menon M; Ragupathy V; Satya RV; Jebaraj J; Aralaguppe SG; Rao C; Pal S; Saravanan S; Murugavel KG; Balakrishnan P; Solomon S; Hewlett I; Ranga U
    J Biol Chem; 2018 Jul; 293(30):11687-11708. PubMed ID: 29773649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site.
    Usami Y; Popov S; Göttlinger HG
    J Virol; 2007 Jun; 81(12):6614-22. PubMed ID: 17428861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein.
    Pornillos O; Higginson DS; Stray KM; Fisher RD; Garrus JE; Payne M; He GP; Wang HE; Morham SG; Sundquist WI
    J Cell Biol; 2003 Aug; 162(3):425-34. PubMed ID: 12900394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein network of HIV budding.
    von Schwedler UK; Stuchell M; Müller B; Ward DM; Chung HY; Morita E; Wang HE; Davis T; He GP; Cimbora DM; Scott A; Kräusslich HG; Kaplan J; Morham SG; Sundquist WI
    Cell; 2003 Sep; 114(6):701-13. PubMed ID: 14505570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.
    Gottwein E; Bodem J; Müller B; Schmechel A; Zentgraf H; Kräusslich HG
    J Virol; 2003 Sep; 77(17):9474-85. PubMed ID: 12915562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The action of TSG101 on HIV-1 budding and related inhibitors].
    Chen HF; Liu XY
    Yao Xue Xue Bao; 2008 Dec; 43(12):1165-70. PubMed ID: 19244744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of domains in gag important for prototypic foamy virus egress.
    Patton GS; Morris SA; Chung W; Bieniasz PD; McClure MO
    J Virol; 2005 May; 79(10):6392-9. PubMed ID: 15858022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ESCRT-I in retroviral budding.
    Martin-Serrano J; Zang T; Bieniasz PD
    J Virol; 2003 Apr; 77(8):4794-804. PubMed ID: 12663786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding.
    Blot V; Perugi F; Gay B; Prévost MC; Briant L; Tangy F; Abriel H; Staub O; Dokhélar MC; Pique C
    J Cell Sci; 2004 May; 117(Pt 11):2357-67. PubMed ID: 15126635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.
    Medina G; Zhang Y; Tang Y; Gottwein E; Vana ML; Bouamr F; Leis J; Carter CA
    Traffic; 2005 Oct; 6(10):880-94. PubMed ID: 16138902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.